The Challenge of Change - Managing Excipients Control
Colorcon
06-Jun-2005 - One of the biggest challenges in catalysed chemical reactions is to remove and recycle the catalyst once the process is complete. A new approach, using Teflon, could make recovery simpler and cut down on the use of solvents, writes Phil Taylor.
06-Jun-2005 - French plant extracts supplier Naturex said today it will buy US rival Pure World for around $37 million (€30m), or $4.30 per share in cash, reports Dominique Patton.
03-Jun-2005 - The use of DNA as a vaccine has been an exciting but elusive prospect in drug development for many years, held back by problems with effectivness and difficulties in production. But this could be about to change, reports Phil Taylor.
02-Jun-2005 - Troubled dosage form company BioProgress has taken its first action to restructure its finances in the wake of its recent problems with increasing overheads and slower trading at its US subsidiary.
02-Jun-2005 - Novagali Pharma, a biopharmaceutical company developing innovative drug delivery systems, has started a Phase I clinical trial in patients with advanced cancer for its oral formulation of the cancer drug paclitaxel.
01-Jun-2005 - Bruker Daltonics introduces a novel protein post translational modification (PTM) discovery tool that represents the first commercially available Electron Transfer Dissociation (ETD) module for PTM discovery and de novo peptide sequencing on high-capacity ion traps
01-Jun-2005 - US generic company Alpharma has turned to an Indian company to supply its finished products and active pharmaceutical ingredients, saying that this could cut its costs in half, reports Phil Taylor.
01-Jun-2005 - UK dosage form specialist BioProgress gave the first insight into its much-anticipated strategic review yesterday, just over a month after the departure of former CEO Graham Hind, reports Phil Taylor.
31-May-2005 - Singapore contract biologics manufacturer A-Bio has added another top pharmaceutical company to its list of customers, just over 18 months after starting operations, reports Phil Taylor.
30-May-2005 - The European Union is to part-finance the creation of a European Theoretical Spectroscopy Facility (ETSF) to advance collaboration across the continent in the field of nanotechnology, reports Phil Taylor.
27-May-2005 - NanoLogix unveils its DNA extraction system for the molecular diagnostics market, which is said to take significantly less time than standard spin column extraction methods.
26-May-2005 - Drug delivery specialist SCOLR Pharma has started pilot testing in Canada of a formulation of the osteoporosis drug raloxifene that promises to improve the absorption of the drug and, potentially, hike its efficacy, reports Phil Taylor.
25-May-2005 - A delivery technology that could allow vaccines to be administered intranasally and does not require refrigeration has passed its first clinical hurdle, reports Phil Taylor.
24-May-2005 - Norbrook Laboratories of Northern Ireland has acquired two anaesthetic product lines and a production facility from Czech company Synthesia, part of the Aliachem group, reports Phil Taylor.
24-May-2005 - An antifungal product in development at France's BioAlliance Pharma has been shown to treat a yeast infection in the mouth with similar efficacy but 10 times less drug than its nearest competitor, reports Phil Taylor.
23-May-2005 - Scientists have reported that a molecule previously thought to play a purely structural and inert role in cells may play a key role in bringing about multidrug resistance in cancer.
20-May-2005 - US researchers have developed the first animal model that clearly defines cancer metastasises in all the same places that human pancreatic cancer spreads to such as the liver, lungs, diaphragm, and adrenal glands.
19-May-2005 - A new understanding of specialised gut hormones may lead to advances in the treatment and management of type 2 diabetes, offering patients a viable option in controlling fluctuating blood glucose levels that is characteristic of the disease.
19-May-2005 - A single injection could replace implants for some drugs that require continuous administration, according to preliminary experiments with a novel drug delivery technology, reports Phil Taylor.
18-May-2005 - Engineers in the US have found a way to modify a plastic so that it can anchor molecules that promote nerve regeneration, blood vessel growth or other biological processes.
17-May-2005 - Fonterra subsidiary Lactose New Zealand will supply GlaxoSmithKline with half its global requirement for inhalation-grade lactose from a newly opened plant, reports Phil Taylor.
16-May-2005 - Croatian pharmaceutical company Pliva has decided to opt out of the proprietary medicines business and refocus its business on the generics and active pharmaceutical ingredients sectors, reports Phil Taylor.
16-May-2005 - According to a latest study, which revealed the presence of a unique genetic biomarker, the quality of life for patients undergoing treatment for colorectal cancer may be significantly improved, potentially minimising the unwanted side effects.
13-May-2005 - DSM is to close down production of bulk vitamin C in the US and cut costs at its plant in Dalry, Scotland, as part of a series of measures to ease pressure on its vitamin business, reports Dominique Patton.
13-May-2005 - US firm Codexis and Shasun Chemicals and Drugs of India have signed a manufacturing and supply agreement for a pharmaceutical intermediate for a generic drug.